Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Triptorelin acetate microspheres for locally advanced or metastatic prostate cancer
ChiCTR2000033188Phase 4Recruiting
- Sponsor
- First Affiliated Hospital, Zhejiang University School of Medicine
- Start
- Jun 2020
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of triptorelin in prostate cancer (PCa), sponsored by First Affiliated Hospital, Zhejiang University School of Medicine. Primary endpoint: Proportion achieving and maintaining castration-level testosterone after repeated dosing. Started Jun 2020; status: recruiting.
02
Drugs
triptorelin
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on ChiCTR2000033188.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000033188.